CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Cash and Bank History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹1,307 Cr | ₹800 Cr | ₹875 Cr | ₹1,565 Cr | ₹1,928 Cr |
What is the latest Cash and Bank ratio of CIPLA ?
| Year | Cash and Bank |
|---|---|
| Mar2026 | ₹1,307 Cr |
| Mar2025 | ₹800 Cr |
| Mar2024 | ₹875 Cr |
| Mar2023 | ₹1,565 Cr |
| Mar2022 | ₹1,928 Cr |
How is Cash and Bank of CIPLA Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,307 Cr | 63.46 | |
| Mar2025 | ₹800 Cr | -8.59 | |
| Mar2024 | ₹875 Cr | -44.08 | |
| Mar2023 | ₹1,565 Cr | -18.87 | |
| Mar2022 | ₹1,928 Cr | - | |
Compare Cash and Bank of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹112,778.8 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| MANKIND PHARMA | ₹95,911.1 Cr | -2.9% | -4.2% | -6.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -2.2% |
-6.1% |
-12.5% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses